ReviewNaunyn-Schmiedeberg's archives of pharmacology2026

Metabolic enzymes and immune receptors as emerging checkpoints in breast cancer: mechanisms, clinical trials, and therapeutic implications.

No numbers read from the abstract.

Not cited yet